Caroline J. Breitbach

Biochemistry, Genetics and Molecular Biology · Life Sciences

34h-index6.0kcitations155works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(92), Cancer Research and Treatments(50), Multiple Myeloma Research and Treatments(49), Monoclonal and Polyclonal Antibodies Research(46), HIV/AIDS drug development and treatment(37)

Publications155 total

Supplemental Figure 2 from Kinetics of Nirogacestat-Mediated Increases in B-cell Maturation Antigen on Plasma Cells Inform Therapeutic Combinations in Multiple Myeloma
2025Open Access
Supplemental Table 1 from Kinetics of Nirogacestat-Mediated Increases in B-cell Maturation Antigen on Plasma Cells Inform Therapeutic Combinations in Multiple Myeloma
2025Open Access
Supplemental Table 3 from Kinetics of Nirogacestat-Mediated Increases in B-cell Maturation Antigen on Plasma Cells Inform Therapeutic Combinations in Multiple Myeloma
2025Open Access
Supplemental Figure 8 from Kinetics of Nirogacestat-Mediated Increases in B-cell Maturation Antigen on Plasma Cells Inform Therapeutic Combinations in Multiple Myeloma
2025Open Access
Supplemental Figure 4 from Kinetics of Nirogacestat-Mediated Increases in B-cell Maturation Antigen on Plasma Cells Inform Therapeutic Combinations in Multiple Myeloma
2025Open Access
Supplemental Table 4 from Kinetics of Nirogacestat-Mediated Increases in B-cell Maturation Antigen on Plasma Cells Inform Therapeutic Combinations in Multiple Myeloma
2025Open Access
Supplemental Figure 5 from Kinetics of Nirogacestat-Mediated Increases in B-cell Maturation Antigen on Plasma Cells Inform Therapeutic Combinations in Multiple Myeloma
2025Open Access
Supplemental Figure 6 from Kinetics of Nirogacestat-Mediated Increases in B-cell Maturation Antigen on Plasma Cells Inform Therapeutic Combinations in Multiple Myeloma
2025Open Access
Supplemental Figure 1 from Kinetics of Nirogacestat-Mediated Increases in B-cell Maturation Antigen on Plasma Cells Inform Therapeutic Combinations in Multiple Myeloma
2025Open Access
Supplemental Figure 7 from Kinetics of Nirogacestat-Mediated Increases in B-cell Maturation Antigen on Plasma Cells Inform Therapeutic Combinations in Multiple Myeloma
2025Open Access
Supplemental Table 2 from Kinetics of Nirogacestat-Mediated Increases in B-cell Maturation Antigen on Plasma Cells Inform Therapeutic Combinations in Multiple Myeloma
2025Open Access
Supplemental Figure 3 from Kinetics of Nirogacestat-Mediated Increases in B-cell Maturation Antigen on Plasma Cells Inform Therapeutic Combinations in Multiple Myeloma
2025Open Access
Supplemental Figure 2 from Kinetics of Nirogacestat-Mediated Increases in B-cell Maturation Antigen on Plasma Cells Inform Therapeutic Combinations in Multiple Myeloma
2025Open Access
Supplemental Table 3 from Kinetics of Nirogacestat-Mediated Increases in B-cell Maturation Antigen on Plasma Cells Inform Therapeutic Combinations in Multiple Myeloma
2025Open Access
Supplemental Figure 1 from Kinetics of Nirogacestat-Mediated Increases in B-cell Maturation Antigen on Plasma Cells Inform Therapeutic Combinations in Multiple Myeloma
2025Open Access
Supplemental Figure 7 from Kinetics of Nirogacestat-Mediated Increases in B-cell Maturation Antigen on Plasma Cells Inform Therapeutic Combinations in Multiple Myeloma
2025Open Access
Supplemental Table 2 from Kinetics of Nirogacestat-Mediated Increases in B-cell Maturation Antigen on Plasma Cells Inform Therapeutic Combinations in Multiple Myeloma
2025Open Access
Supplemental Figure 6 from Kinetics of Nirogacestat-Mediated Increases in B-cell Maturation Antigen on Plasma Cells Inform Therapeutic Combinations in Multiple Myeloma
2025Open Access
Supplemental Table 1 from Kinetics of Nirogacestat-Mediated Increases in B-cell Maturation Antigen on Plasma Cells Inform Therapeutic Combinations in Multiple Myeloma
2025Open Access
Supplemental Table 4 from Kinetics of Nirogacestat-Mediated Increases in B-cell Maturation Antigen on Plasma Cells Inform Therapeutic Combinations in Multiple Myeloma
2025Open Access
page 1 of 8Next →

Frequent Co-authors

John C. Bell(33), David H. Kirn(31), James M. Burke(19), Anne Moon(11), Tae-Ho Hwang(11), Jeong Heo(9), Richard H. Patt(9), Kelley A. Parato(9), Theresa Falls(9), Manijeh Daneshmand(8), Adina Pelusio(8), Jean‐Simon Diallo(8), Brian D. Lichty(7), David F. Stojdl(7), Naomi De Silva(7), Theresa Hickman(6), Harold Atkins(6), Fabrice Le Bœuf(5), Carolina S. Ilkow(5), J. Andrea McCart(5)